Free Trial

Frequency Electronics (FEIM) Competitors

Frequency Electronics logo
$59.90 -1.21 (-1.97%)
As of 02:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

FEIM vs. ALMR, ALNT, EYPT, TRNS, and CTKB

Should you buy Frequency Electronics stock or one of its competitors? MarketBeat compares Frequency Electronics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Frequency Electronics include Alamar Biosciences (ALMR), Allient (ALNT), Eyepoint Pharmaceuticals (EYPT), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry.

How does Frequency Electronics compare to Alamar Biosciences?

Alamar Biosciences (NASDAQ:ALMR) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

Frequency Electronics has lower revenue, but higher earnings than Alamar Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alamar Biosciences$74.21M20.77N/AN/AN/A
Frequency Electronics$67.82M8.69$23.69M$0.7579.87

58.6% of Frequency Electronics shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Alamar Biosciences had 9 more articles in the media than Frequency Electronics. MarketBeat recorded 13 mentions for Alamar Biosciences and 4 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 0.70 beat Alamar Biosciences' score of 0.56 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alamar Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Frequency Electronics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alamar Biosciences presently has a consensus target price of $30.00, suggesting a potential upside of 29.48%. Frequency Electronics has a consensus target price of $43.67, suggesting a potential downside of 27.11%. Given Alamar Biosciences' higher possible upside, research analysts plainly believe Alamar Biosciences is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alamar Biosciences
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Frequency Electronics has a net margin of 10.78% compared to Alamar Biosciences' net margin of 0.00%. Frequency Electronics' return on equity of 12.69% beat Alamar Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Alamar BiosciencesN/A N/A N/A
Frequency Electronics 10.78%12.69%7.84%

Summary

Frequency Electronics beats Alamar Biosciences on 8 of the 13 factors compared between the two stocks.

How does Frequency Electronics compare to Allient?

Frequency Electronics (NASDAQ:FEIM) and Allient (NASDAQ:ALNT) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Frequency Electronics has a net margin of 10.78% compared to Allient's net margin of 4.25%. Frequency Electronics' return on equity of 12.69% beat Allient's return on equity.

Company Net Margins Return on Equity Return on Assets
Frequency Electronics10.78% 12.69% 7.84%
Allient 4.25%12.47%6.37%

Frequency Electronics has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market. Comparatively, Allient has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market.

Frequency Electronics currently has a consensus target price of $43.67, indicating a potential downside of 27.11%. Allient has a consensus target price of $72.25, indicating a potential upside of 13.46%. Given Allient's higher possible upside, analysts plainly believe Allient is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Allient
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Frequency Electronics has higher earnings, but lower revenue than Allient. Allient is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Frequency Electronics$67.82M8.69$23.69M$0.7579.87
Allient$554.48M1.95$22.03M$1.4344.53

In the previous week, Allient had 18 more articles in the media than Frequency Electronics. MarketBeat recorded 22 mentions for Allient and 4 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 0.70 beat Allient's score of 0.27 indicating that Frequency Electronics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Frequency Electronics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Allient
3 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 61.6% of Allient shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by company insiders. Comparatively, 15.0% of Allient shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Frequency Electronics beats Allient on 10 of the 17 factors compared between the two stocks.

How does Frequency Electronics compare to Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ:EYPT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

Eyepoint Pharmaceuticals has a beta of 1.76, meaning that its share price is 76% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market.

99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 4.5% of Eyepoint Pharmaceuticals shares are held by insiders. Comparatively, 28.0% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Frequency Electronics has a net margin of 10.78% compared to Eyepoint Pharmaceuticals' net margin of -3,566.63%. Frequency Electronics' return on equity of 12.69% beat Eyepoint Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Eyepoint Pharmaceuticals-3,566.63% -110.54% -90.15%
Frequency Electronics 10.78%12.69%7.84%

Eyepoint Pharmaceuticals presently has a consensus target price of $31.80, suggesting a potential upside of 136.96%. Frequency Electronics has a consensus target price of $43.67, suggesting a potential downside of 27.11%. Given Eyepoint Pharmaceuticals' higher probable upside, analysts clearly believe Eyepoint Pharmaceuticals is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eyepoint Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.00
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Frequency Electronics has higher revenue and earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eyepoint Pharmaceuticals$31.37M35.87-$231.96M-$3.50N/A
Frequency Electronics$67.82M8.69$23.69M$0.7579.87

In the previous week, Eyepoint Pharmaceuticals had 11 more articles in the media than Frequency Electronics. MarketBeat recorded 15 mentions for Eyepoint Pharmaceuticals and 4 mentions for Frequency Electronics. Eyepoint Pharmaceuticals' average media sentiment score of 0.82 beat Frequency Electronics' score of 0.70 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Eyepoint Pharmaceuticals
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Frequency Electronics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Eyepoint Pharmaceuticals and Frequency Electronics tied by winning 8 of the 16 factors compared between the two stocks.

How does Frequency Electronics compare to Transcat?

Frequency Electronics (NASDAQ:FEIM) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

Frequency Electronics has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market. Comparatively, Transcat has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market.

Frequency Electronics has a net margin of 10.78% compared to Transcat's net margin of 2.47%. Frequency Electronics' return on equity of 12.69% beat Transcat's return on equity.

Company Net Margins Return on Equity Return on Assets
Frequency Electronics10.78% 12.69% 7.84%
Transcat 2.47%6.15%4.15%

Frequency Electronics has higher earnings, but lower revenue than Transcat. Frequency Electronics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Frequency Electronics$67.82M8.69$23.69M$0.7579.87
Transcat$319.69M2.26$14.52M$0.8590.89

Frequency Electronics currently has a consensus target price of $43.67, suggesting a potential downside of 27.11%. Transcat has a consensus target price of $105.33, suggesting a potential upside of 36.35%. Given Transcat's higher possible upside, analysts clearly believe Transcat is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Transcat
2 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.40

58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by company insiders. Comparatively, 2.8% of Transcat shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Frequency Electronics had 2 more articles in the media than Transcat. MarketBeat recorded 4 mentions for Frequency Electronics and 2 mentions for Transcat. Transcat's average media sentiment score of 1.80 beat Frequency Electronics' score of 0.70 indicating that Transcat is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Frequency Electronics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Transcat
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Frequency Electronics and Transcat tied by winning 8 of the 16 factors compared between the two stocks.

How does Frequency Electronics compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

Frequency Electronics has lower revenue, but higher earnings than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cytek Biosciences$201.49M2.23-$66.54M-$0.57N/A
Frequency Electronics$67.82M8.69$23.69M$0.7579.87

Cytek Biosciences has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market.

Cytek Biosciences presently has a consensus target price of $5.69, indicating a potential upside of 63.67%. Frequency Electronics has a consensus target price of $43.67, indicating a potential downside of 27.11%. Given Cytek Biosciences' higher probable upside, analysts clearly believe Cytek Biosciences is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Frequency Electronics has a net margin of 10.78% compared to Cytek Biosciences' net margin of -36.25%. Frequency Electronics' return on equity of 12.69% beat Cytek Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Cytek Biosciences-36.25% -10.07% -7.56%
Frequency Electronics 10.78%12.69%7.84%

69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 10.4% of Cytek Biosciences shares are held by company insiders. Comparatively, 28.0% of Frequency Electronics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Cytek Biosciences had 7 more articles in the media than Frequency Electronics. MarketBeat recorded 11 mentions for Cytek Biosciences and 4 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 0.70 beat Cytek Biosciences' score of -0.18 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cytek Biosciences
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
Frequency Electronics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Frequency Electronics beats Cytek Biosciences on 11 of the 17 factors compared between the two stocks.

Get Frequency Electronics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEIM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FEIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FEIM vs. The Competition

MetricFrequency ElectronicsINSTRU IndustryComputer SectorNASDAQ Exchange
Market Cap$590.08M$3.02B$39.46B$12.48B
Dividend YieldN/A1.05%3.20%5.30%
P/E Ratio79.9463.08163.9125.60
Price / Sales8.693.62623.7775.41
Price / Cash22.5726.1147.8255.34
Price / Book10.424.019.556.72
Net Income$23.69M$75.72M$1.03B$333.73M
7 Day Performance9.29%3.40%0.30%0.38%
1 Month Performance5.87%13.56%9.47%4.02%
1 Year Performance237.49%67.08%164.72%36.37%

Frequency Electronics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FEIM
Frequency Electronics
1.5924 of 5 stars
$59.90
-2.0%
$43.67
-27.1%
+243.3%$590.08M$67.82M79.94200
ALMR
Alamar Biosciences
4.8739 of 5 stars
$23.70
-0.3%
N/AN/A$1.58B$74.21MN/A222
ALNT
Allient
3.7449 of 5 stars
$79.55
+5.2%
$70.75
-11.1%
+99.4%$1.35B$554.48M60.012,478
EYPT
Eyepoint Pharmaceuticals
3.1952 of 5 stars
$13.92
+0.5%
$32.20
+131.4%
+127.2%$1.17B$31.37MN/A120
TRNS
Transcat
3.3734 of 5 stars
$73.46
+1.3%
$105.33
+43.4%
-6.7%$681.33M$319.69M85.891,245

Related Companies and Tools


This page (NASDAQ:FEIM) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners